Biocon gets license for Adagio Therapeutics’ ADG20 for Covid-19 treatment
Biocon Limited said that its subsidiary Biocon Biologics has been given an exclusive license from Adagio Therapeutics, a US-based biotech company, for manufacturing and commercializing ... Read More
Kintor Pharmaceutical gets EUA for Covid drug proxalutamide in Paraguay
Kintor Pharmaceutical has secured an emergency use authorization (EUA) for proxalutamide (GT-0918) for the treatment of hospitalized patients with Covid-19 infections in Paraguay. The EUA ... Read More
FDC Limited launches Favenza – oral suspension of Covid drug Favipiravir
FDC Limited has launched Favenza Oral Suspension - an oral suspension of Favipiravir, in India for the treatment of mild to moderate cases of Covid-19. ... Read More
Morepen Laboratories produces test batch of Sputnik V Covid vaccine
Morepen Laboratories and the Russian Direct Investment Fund (RDIF) announced the production of the test batch of the Russian Sputnik V Covid vaccine in an ... Read More
Panacea Biotec gets manufacturing license for Sputnik V vaccine
Panacea Biotec has secured a manufacturing license from the Drugs Controller General of India (DCGI) for Sputnik V vaccine against Covid-19 following its collaboration with ... Read More
Cipla, Dr. Reddy’s, and others to collaborate on Molnupiravir Covid trial
Five Indian pharma companies – Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals will join forces to undertake a clinical trial ... Read More
Indian government approves use of Moderna’s Covid-19 Vaccine Moderna
US biotech company Moderna has been given emergency use authorization from the Indian government for its Covid-19 Vaccine Moderna (mRNA-1273) in adults aged 18 years ... Read More
Dr. Reddy’s Laboratories launches DRDO’s anti-Covid-19 drug 2-DG
Dr. Reddy’s Laboratories has announced the commercial launch of the Defence Research and Development Organisation’s (DRDO) anti-Covid-19 drug 2-deoxy-D-glucose (2-DG). The Indian pharma giant said ... Read More
Suven Pharma partners with CSIR-IICT to manufacture Molnupiravir and 2-DG
Suven Pharmaceuticals (Suven Pharma), CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram have forged an agreement for ... Read More
Glenmark reports positive interim data from PMS study on Favipiravir
Glenmark Pharmaceuticals said that interim data from its post marketing surveillance (PMS) study on Favipiravir (FabiFlu) in India supports the Covid-19 drug’s safety and effectiveness ... Read More